Literature DB >> 16440426

Detection of gelatinase B activity in serum of gastric cancer patients.

Vesna V Dragutinović1, Nebojsa S Radovanović, Lidija T Izrael-Zivković, Miroslav M Vrvić.   

Abstract

AIM: To determine the proteolytic activity and expression of gelatinase B in serum of gastric cancer patients and their correlation with the stage of the tumor.
METHODS: Sera from 23 patients who underwent surgery for primary gastric cancer as the experimental group and from 11 as the control group were used to determine the proteolytic activity and its inhibition by EDTA and 1,10-phenanthroline. Gelatinase B activity was detected by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and SDS-PAGE zymography.
RESULTS: Proteolytic enzyme activity was increased in gastric cancer patients when compared to the control group (P < 0.05). The proteinases were determined to be metalloproteinases upon inhibition test with specific metalloproteinase inhibitors 1,10-phenanthroline (P < 0.05) and EDTA (P < 0.01). SDS-PAGE and SDS-PAGE zymography revealed gelatinase B (proMMP-9) activity and its molecular mass of 92 ku.
CONCLUSION: Proteinase activity is overexpressed in serum of gastric cancer patients. Gelatinase B in serum plays an important role in the progression of gastric cancer. ProMMP-9 can be used as a marker for invasiveness of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440426      PMCID: PMC4077481          DOI: 10.3748/wjg.v12.i1.105

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Circulating Levels of Matrix Metalloproteinase-9 in Patients with Colorectal Cancer.

Authors:  A M Sonnante; M Correale; M Linsalata; A Di Leo; V Guerra
Journal:  Scand J Gastroenterol       Date:  2000-06       Impact factor: 2.423

Review 2.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

3.  Proteinase K from Tritirachium album Limber.

Authors:  W Ebeling; N Hennrich; M Klockow; H Metz; H D Orth; H Lang
Journal:  Eur J Biochem       Date:  1974-08-15

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Role of MT-MMPs and MMP-2 in pancreatic cancer progression.

Authors:  V Ellenrieder; B Alber; U Lacher; S F Hendler; A Menke; W Boeck; M Wagner; M Wilda; H Friess; M Büchler; G Adler; T M Gress
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

6.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen.

Authors:  L A Liotta; K Tryggvason; S Garbisa; I Hart; C M Foltz; S Shafie
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

Review 7.  Matrix metalloproteinases as therapeutic targets in cancer.

Authors:  Pia Vihinen; Risto Ala-aho; Veli-Matti Kähäri
Journal:  Curr Cancer Drug Targets       Date:  2005-05       Impact factor: 3.428

8.  Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.

Authors:  Sheng Zhang; Li Li; Jian-Yin Lin; Hua Lin
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

9.  Detection of type IV collagenase activity in malignant ascites.

Authors:  Xiao-Min Sun; Wei-Guo Dong; Bao-Ping Yu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

10.  Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

Authors:  E T Waas; R M L M Lomme; J DeGroot; Th Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more
  7 in total

1.  Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.

Authors:  Clara Luz Sampieri; Sol de la Peña; Mariana Ochoa-Lara; Roberto Zenteno-Cuevas; Kenneth León-Córdoba
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

Review 3.  Nanoparticles in Gastrooncology.

Authors:  André Jefremow; Markus F Neurath
Journal:  Visc Med       Date:  2020-03-18

4.  Expression levels of matrix metalloproteinase-9 in human gastric carcinoma.

Authors:  Su-Zuan Chen; Huai-Qi Yao; Sen-Zhi Zhu; Qiu-Yuan Li; Guang-Hua Guo; Jing Yu
Journal:  Oncol Lett       Date:  2014-12-04       Impact factor: 2.967

5.  Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia.

Authors:  Milica Velimirović; Gordana Jevtić Dožudić; Vesna Selaković; Tihomir Stojković; Nela Puškaš; Ivan Zaletel; Milica Živković; Vesna Dragutinović; Tatjana Nikolić; Ankica Jelenković; Djordje Djorović; Aleksandar Mirčić; Nataša D Petronijević
Journal:  Oxid Med Cell Longev       Date:  2018-04-18       Impact factor: 6.543

6.  Proteases from the regenerating gut of the holothurian Eupentacta fraudatrix.

Authors:  Nina E Lamash; Igor Yu Dolmatov
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

7.  The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile.

Authors:  Oi Lian Kon; Tai-Tung Yip; Meng Fatt Ho; Weng Hoong Chan; Wai Keong Wong; Soo Yong Tan; Wai Har Ng; Siok Yuen Kam; Alvin Kh Eng; Patrick Ho; Rosa Viner; Hock Soo Ong; M Priyanthi Kumarasinghe
Journal:  BMC Med Genomics       Date:  2008-10-25       Impact factor: 3.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.